0001140361-14-030442.txt : 20140801 0001140361-14-030442.hdr.sgml : 20140801 20140801180655 ACCESSION NUMBER: 0001140361-14-030442 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140730 FILED AS OF DATE: 20140801 DATE AS OF CHANGE: 20140801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalanche Biotechnologies, Inc. CENTRAL INDEX KEY: 0001501756 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 205258327 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1035 O?BRIEN DRIVE, SUITE A CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-272-6269 MAIL ADDRESS: STREET 1: 1035 O?BRIEN DRIVE, SUITE A CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCLAUGHLIN JOHN PETER CENTRAL INDEX KEY: 0001277967 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36579 FILM NUMBER: 141011098 MAIL ADDRESS: STREET 1: C/O PDL BIOPHARMA, INC. STREET 2: 932 SOUTHWOOD BOULEVARD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 4 1 doc1.xml FORM 4 X0306 4 2014-07-30 0 0001501756 Avalanche Biotechnologies, Inc. AAVL 0001277967 MCLAUGHLIN JOHN PETER C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025 1 0 0 0 Stock Option (Right to Buy) 17.00 2014-07-30 4 A 0 75000 0.00 A 2024-07-29 Common Stock 75000 75000 D One-third (1/3) of the total number of shares subject to the stock option shall vest and become exercisable annually, so that all of the shares subject to the stock option shall be vested and exercisable on the third anniversary of July 30, 2014, subject to the Reporting Person's continuous service to the Issuer. /s/ Michael Swartzburg, Attorney-in-Fact for John McLaughlin 2014-08-01